Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Figure 5 Summary of the main etiologic agents and types of posttransplant thrombotic microangiopathy and their treatment and preventive strategies.
CFB: Complement factor B; CFH: Complement factor H; CNI: Calcineurin inhibitor; IVIG: Intravenous immunoglobulin; mTOR: Mammalian target of rapamycin; TTP: Thrombotic thrombocytopenic purpura.
- Citation: Mubarak M, Raza A, Rashid R, Sapna F, Shakeel S. Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra. World J Transplant 2024; 14(1): 90277
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/90277.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.90277